Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2022. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | 0.00% | 0.00% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+13.55% | 3,174B | |
+13.86% | 89.44B | |
+8.19% | 80.2B | |
-11.92% | 55.78B | |
+20.68% | 46.14B | |
+28.56% | 45.25B | |
-26.77% | 45.34B | |
+77.11% | 41.2B | |
-5.36% | 26.11B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt